Skip to content

Clinical trials

Observational Attention Deficit Disorder with Hyperactivity trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Observational Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20122
20131
20161
20211
20223
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Active, not recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London4
Takeda2
University of Exeter2
Brightlobe Limited1
Elizabeth Kilbey1
Momentum Data1
NHS Tayside1
Royal Devon and Exeter NHS Foundation Trust1
Spanish Foundation for Neurometrics Development1
University of Manchester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity15
Autism Spectrum Disorder5
Anxiety Disorders2
Autistic Disorder2
Bipolar Disorder2
Neurodevelopmental Disorders2
Adjustment Disorders1
Body Dysmorphic Disorders1
COVID-191
Cardiovascular Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.